Jazz Pharmaceuticals plc
JAZZ
$138.81
$2.361.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.13% | 27.58% | 1,253.15% | -115.53% | -35.87% |
| Total Depreciation and Amortization | 1.93% | 1.35% | -0.21% | 2.63% | -2.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.33% | 68.86% | -57.21% | -34.66% | 324.74% |
| Change in Net Operating Assets | -202.98% | 1.58% | -147.53% | 131.16% | -637.36% |
| Cash from Operations | -0.04% | 20.34% | 24.00% | 59.69% | -45.53% |
| Capital Expenditure | -23.16% | -52.14% | -2.71% | 31.66% | -134.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -180.04% | 189.95% | 5.66% | -336.82% | 165.82% |
| Cash from Investing | -190.28% | 183.27% | 5.45% | -367.10% | 158.40% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 98.67% | -7,419.35% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 53,994.12% | -99.84% | 2,114.57% | -94.42% | 60.61% |
| Repurchase of Common Stock | 97.36% | 7.71% | -233.24% | 51.39% | -32.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.36% | 252.98% | -184.84% | 43.62% | -27.79% |
| Foreign Exchange rate Adjustments | -174.54% | 504.61% | 55.30% | -194.91% | 275.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.42% | 1,084.59% | -39.19% | -136.88% | 219.60% |
